Paul Poommipanit, MD
- Director, Coronary Chronic Total Occlusion Program, Harrington Heart and Vascular Institute, University Hospitals
- C0-Director, CHIP and High Risk Coronary Program, Harrington Heart and Vascular Institute, University Hospitals
- Co-Director, CHIP and High Risk Coronary Program, Harrington Heart and Vascular Institute, University Hospitals
- Director, Cardiac Catheterization Laboratory, UH Parma Medical Center
- Clinical Assistant Professor of Medicine, CWRU School of Medicine
- Clinical Associate Professor of Medicine, CWRU School of Medicine
- Specialty: Cardiology-Interventional Cardiology, Cardiology
-
Location:UH Broadview Hts Health Center
5901 E Royalton Rd
Broadview Hts, OH 44147
- Call: 440-882-0075
Biography: Paul Poommipanit, MD
Expertise
Certifications & Memberships
- Cardiovascular Disease - American Board of Internal Medicine
Education
Fellowship | Interventional Cardiology
Interventional Cardiology - Ucla David Geffen School Of Medicine/Ucla Medical Center (2009 - 2010)
Fellowship | Cardiology
Cardiology - Ucla David Geffen School Of Medicine/Ucla Medical Center (2006 - 2009)
Residency | Internal Medicine
Internal Medicine - Ronald Reagan Ucla Medical Center (2003 - 2006)
Medical Education
Tulane University School Of Medicine (2003)
Other Education
Washington University In St Louis (1997)
Undergraduate
Washington University In St Louis (1995)
About
Paul B Poommipanit, MD, is director of the Coronary Chronic Total Occlusion Program, and co-director of the CHIP and High-Risk Coronary Program within University Hospitals Harrington Heart & Vascular Institute. He also serves as director of the cardiac catheterization lab at University Hospitals Parma Medical Center. In addition, Dr. Poommipanit is a clinical associate professor at Case Western Reserve University School of Medicine.
Dr. Poommipanit is board-certified in both cardiovascular disease and interventional cardiology. He earned his medical degree from Tulane University School of Medicine, then completed his residency and two fellowships at the University of California, Los Angeles Medical Center.
Dr. Poommipanit has given numerous professional lectures on interventional cardiology topics and authored more than 30 peer-reviewed publications, abstracts and book chapters. He serves as reviewer for the American College of Cardiology and Catheterization and Cardiovascular Interventions publications.
Dr. Poommipanit is an active member of renowned organizations including the American College of Cardiology, Society of Cardiovascular Angiography and Interventions, American College of Physicians and American Medical Association. He has been recognized with several honors and awards, including being named a Top Doctor by Cleveland Magazine.
Connect with Dr. Poommipanit
LinkedIn | Twitter: @the_real_pooms
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Paul Poommipanit disclosed the following Outside Relationships with Industry:
- - Abbott Laboratories - Honoraria